Trial Profile

A study of cannabidiol as treatment for early psychosis

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 04 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cannabidiol (Primary)
Indications Psychotic disorders
Focus Adverse reactions; Therapeutic Use

Most Recent Events

17 Dec 2018 According to an INSYS Therapeutics, Inc. media release, this study is expected to be opened in the first half of 2019.
15 Sep 2018 New trial record
04 Sep 2018 According to an INSYS Therapeutics media release, this trial is being conducted under collaboration with the University of California (UC) San Diego School of Medicines Center for Medicinal Cannabis Research (CMCR) and is expected to commence in 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com